BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20525546)

  • 1. [Reasons for stopping and restarting tuberculosis treatment in Libreville (Gabon)].
    Mvé MT; Bisvigou U; Barry NC; Ondo CE; Nkoghe D
    Sante; 2010; 20(1):31-4. PubMed ID: 20525546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV seroprevalence among tuberculosis patients in Nkembo Hospital, Libreville, Gabon. Short note].
    Nkoghe D; Toung Mve M; Nnegue S; Okome Nkoume M; Iba BJ; Hypolite J; Leonard P; Kendjo E
    Bull Soc Pathol Exot; 2005 Jun; 98(2):121-2. PubMed ID: 16050379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choosing incentives to stimulate tuberculosis treatment compliance in a poor county in Rio de Janeiro state, Brazil.
    Belo MT; Selig L; Luiz RR; Hanson C; Luna AL; Teixeira EG; Trajman A
    Med Sci Monit; 2006 May; 12(5):PH1-5. PubMed ID: 16641886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DOTS in Cambodia. Directly observed treatment with short-course chemotherapy.
    Norval PY; San KK; Bakhim T; Rith DN; Ahn DI; Blanc L
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):44-51. PubMed ID: 9562110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cotrimoxazole prophylaxis in HIV-infected individuals after completing anti-tuberculosis treatment in Thyolo, Malawi.
    Zachariah R; Spielmann MP; Harries AD; Gomani P; Bakali E
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1046-50. PubMed ID: 12546111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with compliance among tuberculosis patients in Thailand.
    Lertmaharit S; Kamol-Ratankul P; Sawert H; Jittimanee S; Wangmanee S
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S149-56. PubMed ID: 16623020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease, and factors affecting treatment compliance.
    Liam CK; Lim KH; Wong CM; Tang BG
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):300-9. PubMed ID: 10206500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence of and factors for non-compliance to antituberculous treatment].
    Cáceres Fde M; Orozco LC
    Biomedica; 2007 Dec; 27(4):498-504. PubMed ID: 18320117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of increasing incentives on adherence to tuberculosis directly observed therapy.
    Davidson H; Schluger NW; Feldman PH; Valentine DP; Telzak EE; Laufer FN
    Int J Tuberc Lung Dis; 2000 Sep; 4(9):860-5. PubMed ID: 10985655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of and barriers to public sector tuberculosis services in India.
    Dandona R; Dandona L; Mishra A; Dhingra S; Venkatagopalakrishna K; Chauhan LS
    Natl Med J India; 2004; 17(6):292-9. PubMed ID: 15736548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects and treatment outcome in HIV-associated pulmonary tuberculosis: an experience from a Thai referral centre.
    Hongthiamthong P; Riantawan P; Subhannachart P; Fuangtong P
    J Med Assoc Thai; 1994 Oct; 77(10):520-5. PubMed ID: 7745373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women and tuberculosis.
    Connolly M; Nunn P
    World Health Stat Q; 1996; 49(2):115-9. PubMed ID: 9050189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting patient adherence to DOTS in urban Kathmandu, Nepal.
    Bam TS; Gunneberg C; Chamroonsawasdi K; Bam DS; Aalberg O; Kasland O; Shiyalap K; Srisorrachatr S
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):270-6. PubMed ID: 16562706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors contributing to poor compliance with anti-TB treatment among tuberculosis patients.
    Naing NN; D'Este C; Isa AR; Salleh R; Bakar N; Mahmod MR
    Southeast Asian J Trop Med Public Health; 2001 Jun; 32(2):369-82. PubMed ID: 11556591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of childhood tuberculosis in Libreville, Gabon from 1997 to 2001].
    Engohan Alloghe E; Toung Mve M; Ramarojoana S; Iba J; Nkoghe D
    Med Trop (Mars); 2006 Oct; 66(5):469-71. PubMed ID: 17201292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of treatment failure among tuberculosis patients under DOTS strategy in Egypt.
    Morsy AM; Zaher HH; Hassan MH; Shouman A
    East Mediterr Health J; 2003 Jul; 9(4):689-701. PubMed ID: 15748066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of the DOTS strategy for tuberculosis in the Leningrad Region, Russian Federation (1998-1999).
    Ruohonen RP; Goloubeva TM; Trnka L; Fomin MM; Zhemkova GA; Sinitsyn AV; Lichachev AA; Koskela KG
    Int J Tuberc Lung Dis; 2002 Mar; 6(3):192-7. PubMed ID: 11934136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing completion of treatment among tuberculosis patients in Mbarara District, Uganda.
    Nuwaha F
    East Afr Med J; 1997 Nov; 74(11):690-3. PubMed ID: 9557437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subset of clinical status of pulmonary tuberculosis in Southern Taiwan.
    Tsai MS; Chong IW; Hwang JJ; Wang TH; Huang MS
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):136-9. PubMed ID: 15272756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.